Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Trimipramine=bad; SSRI receptor affinity values

Posted by Shawn. T. on July 20, 2002, at 23:50:46

In reply to trimipramine (anti-histamine vs. anti-cholenergic) » katekite, posted by fachad on July 20, 2002, at 17:07:44

Note that you'll lose the anti-histamine
side effects after a couple weeks. Your body develops a tolerance over the course of a couple weeks I believe. Note that these binding values are not in vivo.

SSRI histamine (H1) binding values:
Prozac: 470
Zoloft: 53,000
Paxil: 66,000
Fluvox: 2,900
Celexa: 220

SSRI acetylcholine binding values:
Prozac: 445
Zoloft: 5,800
Paxil: 720
Fluvox: 8,900
Celexa: 3,100

http://www.erowid.org/chemicals/ssris/ssris_info1.shtml

Trimipramine is awful! Is it really worth the negative effects on learning to get to sleep when other sleep aids exist? I really can't present a more logical argument than what follows. I just don't understand why people don't care. An antidepressant should show cognitive benefits.
There is a "possible correlation between the reduction in LTP expression and learning deficits produced by chronic administration of trimipramine."

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8476377&dopt=Abstract

"Taken together the present data suggest that the loss of LTP maintenance in TRIM-treated animals is more likely the result of the disruption by trimipramine of cellular processes that follow LTP induction. In addition, the results provide evidence for a possible correlation between the reduction in LTP expression and learning deficits produced by chronic administration of trimipramine."

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8476377&dopt=Abstract

"Whereas the binding characteristics of various agonist and antagonist ligands to the N-methyl-D-aspartate and the AMPA receptors were not modified by trimipramine treatment, there was a significant reduction in the increase in 3H-AMPA binding elicited by PLA2 treatment. Since activation of PLA2 has been reported to play a critical role in the formation of long-term potentiation, possibly mediated through a modification of the AMPA receptors, the results strengthen the hypothesis that PLA2-induced modification of 3H-AMPA binding is an important component of synaptic plasticity."

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7912839&dopt=Abstract


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Shawn. T. thread:113043
URL: http://www.dr-bob.org/babble/20020718/msgs/113102.html